Lung-MAP is a cancer clinical trial designed to quickly and efficiently test new treatments for advanced non-small cell lung cancers - which make up about 85 percent of all lung cancer diagnoses in the United States. Lung-MAP is offered at hospitals..
Relevance: 11.3485565